Lexeo Therapeutics (LXEO) Earnings Date, Estimates & Call Transcripts → Who are Nvidia’s Silent Partners? (From Weiss Ratings) (Ad) Free LXEO Stock Alerts $15.48 +0.32 (+2.11%) (As of 05/23/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateNov. 4EstimatedActual EPS (May. 9) -$0.77 Missed By -$0.01 Consensus EPS (May. 9) -$0.76 Get Lexeo Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for LXEO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLXEO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LXEO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution Lexeo Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($1.10)($1.10)($1.10)Q2 20241($1.09)($1.09)($1.09)Q3 20241($1.09)($1.09)($1.09)Q4 20241($1.08)($1.08)($1.08)FY 20244($4.36)($4.36)($4.36)LXEO Earnings Date and InformationLexeo Therapeutics last released its quarterly earnings results on May 9th, 2024. The reported ($0.77) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.76) by $0.01. Lexeo Therapeutics has generated ($22.29) earnings per share over the last year (($22.29) diluted earnings per share). Earnings for Lexeo Therapeutics are expected to grow in the coming year, from ($2.61) to ($2.42) per share. Lexeo Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.Read More Lexeo Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 11/4/2024(Estimated)------- 5/9/2024Q1 2024($0.76)($0.77)($0.01)($0.77)--3/11/2024Q4 2023($0.71)($0.86)($0.15)($0.86)--12/11/2023Q3 2023($0.96)($12.36)($11.40)($12.36)--10/30/2023Q2 2023-($8.30)($8.30)($8.30)-- Lexeo Therapeutics Earnings - Frequently Asked Questions When is Lexeo Therapeutics's earnings date? Lexeo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on LXEO's earnings history. Did Lexeo Therapeutics beat their earnings estimates last quarter? In the previous quarter, Lexeo Therapeutics (NASDAQ:LXEO) missed the analysts' consensus estimate of ($0.76) by $0.01 with a reported earnings per share (EPS) of ($0.77). Learn more on analysts' earnings estimate vs. LXEO's actual earnings. How much revenue does Lexeo Therapeutics generate each year? Lexeo Therapeutics (NASDAQ:LXEO) has a recorded annual revenue of $650,000.00. How much profit does Lexeo Therapeutics generate each year? Lexeo Therapeutics (NASDAQ:LXEO) has a recorded net income of -$66.39 million. LXEO has generated -$22.29 earnings per share over the last four quarters. What is Lexeo Therapeutics's EPS forecast for next year? Lexeo Therapeutics's earnings are expected to grow from ($2.61) per share to ($2.42) per share in the next year. More Earnings Resources from MarketBeat Related Companies: VYGR Earnings Date FATE Earnings Date EDIT Earnings Date TCRX Earnings Date OCGN Earnings Date REPL Earnings Date CADL Earnings Date CCCC Earnings Date ALLO Earnings Date ALEC Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: PDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets Uncertainty This page (NASDAQ:LXEO) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis could mean the end of the U.S dollar…Colonial MetalsThis military-backed stock “owns” AI marketPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.